Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving targeted temperature management at 33 °C: the ISOCRATE pilot randomized controlled trial

PURPOSE: While targeted temperature management (TTM) has been recommended in patients with shockable cardiac arrest (CA) and suggested in patients with non-shockable rhythms, few data exist regarding the impact of the rewarming rate on systemic inflammation. We compared serum levels of the proinflam...

Descripción completa

Detalles Bibliográficos
Autores principales: Lascarrou, Jean-Baptiste, Guichard, Elie, Reignier, Jean, Le Gouge, Amélie, Pouplet, Caroline, Martin, Stéphanie, Lacherade, Jean-Claude, Colin, Gwenhael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680374/
https://www.ncbi.nlm.nih.gov/pubmed/34920723
http://dx.doi.org/10.1186/s13054-021-03842-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680374/
https://www.ncbi.nlm.nih.gov/pubmed/34920723
http://dx.doi.org/10.1186/s13054-021-03842-9

Ejemplares similares